We used search terms of “immunotherapy”, “gynecological cancer”, “recurrent ovarian cancer”, “refractory ovarian cancer”, “PD-1/PD-L1 inhibitor”, and “blockade” in different combinations. Here, PDCD1 is linked to ovarian carcinoma.